Rituximab for Prevention of Rejection After Renal Transplantation

This study has been completed.
Sponsor:
Collaborators:
Hoffmann-La Roche
Astellas Pharma GmbH
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT00565331
First received: November 28, 2007
Last updated: June 19, 2015
Last verified: June 2015